Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-751 in Children With Relapsed or Refractory Neuroblastoma
NCT00436852Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Jan 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of abt-751 in neuroblastoma, sponsored by Children's Oncology Group. Started Jan 2007; status: completed.
02
Drugs
abt-751
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00436852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436852.